Regent Pacific's Deep Longevity Announces U.S. Market Entry in 2026
Regent Pacific's subsidiary, Deep Longevity, will enter the U.S. market in Q1 2026, establishing a sales team to build partnerships in the wellness sector. The expansion targets the southeastern U.S., aiming to tap into the $6.8 trillion wellness market. The first salespeople will join on January 1, 2026.
Regent Pacific Group Ltd. has announced that its subsidiary, Deep Longevity, Inc., will launch a strategic expansion into the United States in the first quarter of 2026. Deep Longevity, a leader in explainable AI-driven aging clocks and longevity science, will establish a U.S.-based sales organization, with the first two salespeople joining on January 1, 2026. The team will focus on building partnerships with longevity platforms, health apps, diagnostic labs, wellness clinics, corporate wellness programs, insurers, employers, and premium health service providers, initially targeting the southeastern region of the U.S. This move positions the company to tap into the world’s largest wellness market, valued at over US$6.8 trillion. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regent Pacific Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251201-11936218), on December 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
